[Vaccine-manufacturing] Covid-19 Vaccines: Novavax Reports More Delays - The New York Times

James Love james.love at keionline.org
Tue May 11 12:44:33 PDT 2021


The delays, announced during an earnings call with investors, are the
latest setback for the little-known Maryland company, which was granted up
to $1.6 billion from the U.S. federal government last year and whose
product has shown robust results in clinical trials. Despite these wins,
the company has struggled to demonstrate that it can deliver on its promise
to supply the world with 2 billion doses this year.

More information about the Vaccine-manufacturing mailing list